Stocks · News reference
Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 29, 2026, 9:21 PM
- Checked
- Jul 29, 2026, 9:20 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Ingevity Corp (NGVT)
Filed: 2026-07-29 AccNo: 0001653477-26-000044 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarIngevity’s Evotherm P35 Secures BASt Approval For Warm‑Mix Asphalt In Germany
Approval reflects alignment with evolving regulatory and performance standard for German market requirementsIngevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has received approval from
Read original at benzinga